After BioInnovate, Michelle applied her expertise to become a teaching assistant in Global BioDesign in Stanford University. Following this, she has become an integral Senior System Engineer for iRhythm Technologies, a company from Stanford's BioDesign program, which went public late 2016 with an IPO of over US$100million.